
News|Articles|June 18, 2024
The Nuances of Patient Selection: Why Some Trials Need Eligibility Adjudication
Author(s)WCG
Patient selection can be a nuanced process in clinical trials, particularly those involving therapeutic areas with more complex or subjective inclusion/exclusion criteria. Determining patient eligibility may often depend on factors that require clinical expertise in such areas as disease progression, comorbidities, genetic mutations, and disease severity. Discover the role eligibility adjudication committees play in ensuring trial success.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
3
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
4
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
5